HeadCheck Health vs Prim6: Revenue, Funding & Team Size Compared
HeadCheck Health generates $55.9K in revenue; Prim6 generates $47.4K. HeadCheck Health is 1.2× bigger than Prim6 by revenue. The table below compares HeadCheck Health and Prim6 on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $55.9K | $47.4K |
| Valuation | Not disclosed | $711.5K |
| Funding raised | Not disclosed | $180K |
| Team size | 3 | 2 |
| Founded | 2013 | 2021 |
| HQ | Vancouver, Canada | Indianapolis, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
HeadCheck Health at a glance
HeadCheck Health generates $55.9K in revenue with 3 employees, headquartered in Vancouver, Canada.
- Revenue
- $55.9K
- Team size
- 3
- Founded
- 2013
Software-as-a-Service (SaaS) concussion testing & compliance monitoring solution that works for any sports organization or clinic.
Prim6 at a glance
Prim6 generates $47.4K in revenue with 2 employees, headquartered in Indianapolis, United States.
- Revenue
- $47.4K
- Valuation
- $711.5K
- Funding
- $180K
- Team size
- 2
- Founded
- 2021
Big data intelligence company offering a tokenized blockchain asset management SaaS
Other HeadCheck Health alternatives
HeadCheck Health competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
HeadCheck Health vs Prim6: frequently asked questions
Is HeadCheck Health or Prim6 bigger?
HeadCheck Health is the bigger company by revenue, at $55.9K against $47.4K for Prim6.
How much revenue does HeadCheck Health make?
HeadCheck Health generates $55.9K in annual revenue with a team of 3.
How much revenue does Prim6 make?
Prim6 generates $47.4K in annual revenue with a team of 2.
How much funding has Prim6 raised?
Prim6 has raised $180K in total funding since it was founded in 2021.